Systematic review of exercise for the treatment of pediatric metabolic dysfunction-associated steatotic liver disease.

<h4>Background & aims</h4>Steatotic liver disease affects approximately 1 in 10 children in the U.S. and increases the risk of cirrhosis, diabetes, and cardiovascular disease. Lifestyle modification centered on increased physical activity and dietary improvement is the primary manage...

Full description

Saved in:
Bibliographic Details
Main Authors: Martha R Smith, Elizabeth L Yu, Ghattas J Malki, Kimberly P Newton, Nidhi P Goyal, Karen M Heskett, Jeffrey B Schwimmer
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2024-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0314542
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841555413977268224
author Martha R Smith
Elizabeth L Yu
Ghattas J Malki
Kimberly P Newton
Nidhi P Goyal
Karen M Heskett
Jeffrey B Schwimmer
author_facet Martha R Smith
Elizabeth L Yu
Ghattas J Malki
Kimberly P Newton
Nidhi P Goyal
Karen M Heskett
Jeffrey B Schwimmer
author_sort Martha R Smith
collection DOAJ
description <h4>Background & aims</h4>Steatotic liver disease affects approximately 1 in 10 children in the U.S. and increases the risk of cirrhosis, diabetes, and cardiovascular disease. Lifestyle modification centered on increased physical activity and dietary improvement is the primary management approach. However, significant gaps in the literature hinder the establishment of exercise as a targeted therapeutic strategy for pediatric metabolic dysfunction-associated steatotic liver disease (MASLD), previously known as nonalcoholic fatty liver disease (NAFLD). We performed a systematic review of studies assessing the impact of exercise interventions on validated hepatic outcomes in children with NAFLD.<h4>Methods</h4>We searched CENTRAL, PubMed, Embase, Web of Science, CINAHL, and Google Scholar on June 5 and 6, 2023, for studies in English involving children aged 0 to 19 years diagnosed with NAFLD or at increased risk for NAFLD due to overweight or obesity. We updated the search on August 8, 2024. Eligible studies were required to examine the impact of exercise interventions on hepatic steatosis or liver chemistry. The risk of bias was assessed with RoB2 and ROBINS-I. Data extraction was performed by two independent reviewers.<h4>Results</h4>After screening 1578 unique records, 16 studies involving 998 children were included. This comprised seven studies comparing exercise intervention with non-exercising controls, three uncontrolled studies of exercise intervention, two studies comparing exercise plus lifestyle interventions with lifestyle interventions alone, and nine studies comparing different types of exercise interventions. Five of the 11 studies that evaluated hepatic steatosis reported an absolute decrease of 1% to 3%. In the nine studies that evaluated liver chemistry, no significant changes were observed.<h4>Conclusions</h4>Evidence supporting exercise intervention for the treatment of pediatric MASLD is limited. Existing studies were constrained by their methodological approaches; thus, there is a pressing need for high-quality future research. This will enable the development of precise, evidence-based exercise guidelines crucial for the effective clinical management of this condition.
format Article
id doaj-art-c5609990225246a7acde47092ea271e0
institution Kabale University
issn 1932-6203
language English
publishDate 2024-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-c5609990225246a7acde47092ea271e02025-01-08T05:33:24ZengPublic Library of Science (PLoS)PLoS ONE1932-62032024-01-011912e031454210.1371/journal.pone.0314542Systematic review of exercise for the treatment of pediatric metabolic dysfunction-associated steatotic liver disease.Martha R SmithElizabeth L YuGhattas J MalkiKimberly P NewtonNidhi P GoyalKaren M HeskettJeffrey B Schwimmer<h4>Background & aims</h4>Steatotic liver disease affects approximately 1 in 10 children in the U.S. and increases the risk of cirrhosis, diabetes, and cardiovascular disease. Lifestyle modification centered on increased physical activity and dietary improvement is the primary management approach. However, significant gaps in the literature hinder the establishment of exercise as a targeted therapeutic strategy for pediatric metabolic dysfunction-associated steatotic liver disease (MASLD), previously known as nonalcoholic fatty liver disease (NAFLD). We performed a systematic review of studies assessing the impact of exercise interventions on validated hepatic outcomes in children with NAFLD.<h4>Methods</h4>We searched CENTRAL, PubMed, Embase, Web of Science, CINAHL, and Google Scholar on June 5 and 6, 2023, for studies in English involving children aged 0 to 19 years diagnosed with NAFLD or at increased risk for NAFLD due to overweight or obesity. We updated the search on August 8, 2024. Eligible studies were required to examine the impact of exercise interventions on hepatic steatosis or liver chemistry. The risk of bias was assessed with RoB2 and ROBINS-I. Data extraction was performed by two independent reviewers.<h4>Results</h4>After screening 1578 unique records, 16 studies involving 998 children were included. This comprised seven studies comparing exercise intervention with non-exercising controls, three uncontrolled studies of exercise intervention, two studies comparing exercise plus lifestyle interventions with lifestyle interventions alone, and nine studies comparing different types of exercise interventions. Five of the 11 studies that evaluated hepatic steatosis reported an absolute decrease of 1% to 3%. In the nine studies that evaluated liver chemistry, no significant changes were observed.<h4>Conclusions</h4>Evidence supporting exercise intervention for the treatment of pediatric MASLD is limited. Existing studies were constrained by their methodological approaches; thus, there is a pressing need for high-quality future research. This will enable the development of precise, evidence-based exercise guidelines crucial for the effective clinical management of this condition.https://doi.org/10.1371/journal.pone.0314542
spellingShingle Martha R Smith
Elizabeth L Yu
Ghattas J Malki
Kimberly P Newton
Nidhi P Goyal
Karen M Heskett
Jeffrey B Schwimmer
Systematic review of exercise for the treatment of pediatric metabolic dysfunction-associated steatotic liver disease.
PLoS ONE
title Systematic review of exercise for the treatment of pediatric metabolic dysfunction-associated steatotic liver disease.
title_full Systematic review of exercise for the treatment of pediatric metabolic dysfunction-associated steatotic liver disease.
title_fullStr Systematic review of exercise for the treatment of pediatric metabolic dysfunction-associated steatotic liver disease.
title_full_unstemmed Systematic review of exercise for the treatment of pediatric metabolic dysfunction-associated steatotic liver disease.
title_short Systematic review of exercise for the treatment of pediatric metabolic dysfunction-associated steatotic liver disease.
title_sort systematic review of exercise for the treatment of pediatric metabolic dysfunction associated steatotic liver disease
url https://doi.org/10.1371/journal.pone.0314542
work_keys_str_mv AT martharsmith systematicreviewofexerciseforthetreatmentofpediatricmetabolicdysfunctionassociatedsteatoticliverdisease
AT elizabethlyu systematicreviewofexerciseforthetreatmentofpediatricmetabolicdysfunctionassociatedsteatoticliverdisease
AT ghattasjmalki systematicreviewofexerciseforthetreatmentofpediatricmetabolicdysfunctionassociatedsteatoticliverdisease
AT kimberlypnewton systematicreviewofexerciseforthetreatmentofpediatricmetabolicdysfunctionassociatedsteatoticliverdisease
AT nidhipgoyal systematicreviewofexerciseforthetreatmentofpediatricmetabolicdysfunctionassociatedsteatoticliverdisease
AT karenmheskett systematicreviewofexerciseforthetreatmentofpediatricmetabolicdysfunctionassociatedsteatoticliverdisease
AT jeffreybschwimmer systematicreviewofexerciseforthetreatmentofpediatricmetabolicdysfunctionassociatedsteatoticliverdisease